ArticleHealth affairs scholar2026
Pharmacist participation as providers in Ohio Medicaid: an analysis of claims, services, and billing patterns, 2021-2025.
Article in Health affairs scholar, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: States increasingly recognize pharmacists as medical-benefit providers, yet participation under Medicaid is not well documented. Methods: We conducted a retrospective descriptive analysis of pharmacist-submitted claims to the Ohio Department of Medicaid from January 2017 to January 2025. Claims included current procedural terminology/International Classification of Diseases-10 codes, paid/denied status, payment amounts, and place of service. Results: Pharmacists submitted 1424 claims before implementation and nearly 250 000 afterward, with more than 85% paid and $4.4 million reimbursed. Most claims occurred in team-based settings (Federally Qualified Health Centers [55%] and office practices [41%]) while community pharmacy billing was rare (0.19%). Common services included evaluation and management visits, preventive counseling, and continuous glucose monitoring; leading diagnoses were type 2 diabetes, hypertension, and nicotine dependence. Conclusion: Recognition of pharmacists as medical-benefit providers produced rapid participation at modest cost, primarily in integrated clinical settings. These findings suggest that streamlined referral processes and improved billing support may expand participation, particularly in community pharmacies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.